Marshall Wace’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $859K | Buy |
82,630
+44,025
| +114% | +$457K | ﹤0.01% | 1795 |
|
|
2025
Q1 | $509K | Buy |
+38,605
| New | +$509K | ﹤0.01% | 1961 |
|
|
2024
Q3 | – | Sell |
-30,038
| Closed | -$811K | – | 2688 |
|
|
2024
Q2 | $811K | Buy |
+30,038
| New | +$811K | ﹤0.01% | 1617 |
|
|
2023
Q2 | – | Sell |
-43,292
| Closed | -$1.81M | – | 2442 |
|
|
2023
Q1 | $1.81M | Sell |
43,292
-389
| -0.9% | -$16.2K | ﹤0.01% | 1200 |
|
|
2022
Q4 | $1.48M | Sell |
43,681
-17,955
| -29% | -$609K | ﹤0.01% | 1462 |
|
|
2022
Q3 | $3.03M | Buy |
61,636
+28,880
| +88% | +$1.42M | 0.01% | 1395 |
|
|
2022
Q2 | $1.29M | Buy |
32,756
+15,780
| +93% | +$620K | ﹤0.01% | 1770 |
|
|
2022
Q1 | $627K | Sell |
16,976
-49,410
| -74% | -$1.82M | ﹤0.01% | 2026 |
|
|
2021
Q4 | $6.49M | Buy |
+66,386
| New | +$6.49M | 0.01% | 1070 |
|
|
2021
Q3 | – | Sell |
-10,143
| Closed | -$1.27M | – | 2763 |
|
|
2021
Q2 | $1.27M | Buy |
+10,143
| New | +$1.27M | 0.01% | 1314 |
|
|
2020
Q4 | – | Sell |
-34,102
| Closed | -$2.54M | – | 1994 |
|
|
2020
Q3 | $2.54M | Buy |
+34,102
| New | +$2.54M | 0.02% | 717 |
|
|
2018
Q4 | – | Sell |
-850
| Closed | -$396K | – | 1772 |
|
|
2018
Q3 | $396K | Buy |
+850
| New | +$396K | ﹤0.01% | 970 |
|
|
2016
Q3 | – | Sell |
-1,207
| Closed | -$506K | – | 1101 |
|
|
2016
Q2 | $506K | Buy |
+1,207
| New | +$506K | ﹤0.01% | 812 |
|